WallStreetZenWallStreetZen

NASDAQ: GMAB
Genmab A Stock

Open Broker Account
$35.45+1.65 (+4.88%)
Updated Oct 4, 2022
GMAB Price
$35.45
Fair Value Price
$50.33
Market Cap
$23.30B
52 Week Low
$26.19
52 Week High
$47.28
P/E
42.87x
P/B
6.97x
P/S
14.89x
PEG
1.74x
Dividend Yield
N/A
Revenue
$1.39B
Earnings
$556.46M
Gross Margin
100%
Operating Margin
58.5%
Profit Margin
38.8%
Debt to Equity
0.12
Operating Cash Flow
$314M
Beta
0.8
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

GMAB Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GMAB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GMAB ($35.45) is undervalued by 29.56% relative to our estimate of its Fair Value price of $50.33 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
GMAB ($35.45) is significantly undervalued by 29.56% relative to our estimate of its Fair Value price of $50.33 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
GMAB ($35.45) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more GMAB due diligence checks available for Premium users.

Be the first to know about important GMAB news, forecast changes, insider trades & much more!

GMAB News

Valuation

GMAB fair value

Fair Value of GMAB stock based on Discounted Cash Flow (DCF)
Price
$35.45
Fair Value
$50.33
Undervalued by
29.56%
GMAB ($35.45) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
GMAB ($35.45) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
GMAB ($35.45) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

GMAB price to earnings (PE)

For valuing profitable companies with steady earnings
Company
42.87x
Industry
15.62x
Market
29.05x
GMAB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
GMAB is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

GMAB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.97x
Industry
4.53x
GMAB is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GMAB price to earnings growth (PEG)

For valuing profitable companies with growth potential
GMAB is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

GMAB's financial health

Profit margin

Revenue
$444.1M
Net Income
$265.6M
Profit Margin
59.8%
GMAB's Earnings (EBIT) of $815.98M... subscribe to Premium to read more.
Interest Coverage Financials
GMAB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.9B
Liabilities
$420.5M
Debt to equity
0.12
GMAB's short-term assets ($3.48B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GMAB's short-term assets ($3.48B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GMAB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$134.7M
Investing
-$80.9M
Financing
-$30.1M
GMAB's operating cash flow ($305.19M)... subscribe to Premium to read more.
Debt Coverage Financials

GMAB vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
GMAB$23.30B+4.88%42.87x6.97x
ALNY$24.15B+2.26%-24.63x137.21x
RPRX$25.30B+3.68%39.31x2.43x
SGEN$25.67B+1.07%-34.53x8.75x
ARGX$20.34B+5.27%-21.02x6.78x

Genmab A Stock FAQ

What is Genmab A's quote symbol?

NASDAQ: GMAB) Genmab A trades on the NASDAQ under the ticker symbol GMAB. Genmab A stock quotes can also be displayed as NASDAQ: GMAB.

If you're new to stock investing, here's how to buy Genmab A stock.

What is the 52 week high and low for Genmab A (NASDAQ: GMAB)?

(NASDAQ: GMAB) Genmab A's 52-week high was $47.28, and its 52-week low was $26.19. It is currently -25.02% from its 52-week high and 35.36% from its 52-week low.

How much is Genmab A stock worth today?

(NASDAQ: GMAB) Genmab A currently has 65,734,141 outstanding shares. With Genmab A stock trading at $35.45 per share, the total value of Genmab A stock (market capitalization) is $23.30B.

Genmab A stock was originally listed at a price of $3.77 in Jun 1, 2009. If you had invested in Genmab A stock at $3.77, your return over the last 13 years would have been 839.82%, for an annualized return of 18.81% (not including any dividends or dividend reinvestments).

How much is Genmab A's stock price per share?

(NASDAQ: GMAB) Genmab A stock price per share is $35.45 today (as of Oct 4, 2022).

What is Genmab A's Market Cap?

(NASDAQ: GMAB) Genmab A's market cap is $23.30B, as of Oct 5, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Genmab A's market cap is calculated by multiplying GMAB's current stock price of $35.45 by GMAB's total outstanding shares of 65,734,141.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.